KLI
CYTXW

Kelman-Lazarov Inc’s Cytori Therapeutics Inc Warrant CYTXW Stock Holding History

Kelman-Lazarov Inc’s Portfolio CYTXW Stock Details CYTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-200
Closed -$159 – 386
2016
Q3 		$159 Hold
200
– – ﹤0.01% 372
2016
Q2 		$160 Buy
+200
New +$134 ﹤0.01% 365

Other funds holding CYTXW

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Kelman-Lazarov Inc's CYTXW Position: Q4 2016 in Review

Kelman-Lazarov Inc sold out of Cytori Therapeutics Inc Warrant (CYTXW) in Q4 2016, closing a stake of 200 shares — an estimated $159 sold.

Kelman-Lazarov Inc first reported a position in CYTXW in Q2 2016 and held it in 2 quarters. The position peaked at $160 in Q2 2016. 3 funds tracked by Wall St. Rank hold CYTXW as of Q4 2016.

  • Kelman-Lazarov Inc reported no remaining Cytori Therapeutics Inc Warrant position as of Q4 2016 after selling out during the quarter.
  • Kelman-Lazarov Inc sold 200 Cytori Therapeutics Inc Warrant shares in Q4 2016, an estimated $159.
  • Kelman-Lazarov Inc first reported a position in Cytori Therapeutics Inc Warrant in Q2 2016 and held it in 2 quarters.
  • Kelman-Lazarov Inc's Cytori Therapeutics Inc Warrant position peaked at $160 in Q2 2016.
  • 3 funds tracked by Wall St. Rank held Cytori Therapeutics Inc Warrant as of Q4 2016.

Based on Kelman-Lazarov Inc's 13F filing for Q4 2016, filed 17 Jan 2017.